首例需免疫抑制的特纳综合征患者卵巢皮质同种异体移植成功:广泛意义
一名20岁非嵌合型45-XO特纳综合征无月经女性,接受其22岁46-XX fertile姐姐的卵巢组织移植,虽HLA匹配但ABO血型不合。术后5个月恢复正常月经并自然妊娠分娩正常女婴。该首例需免疫抑制的卵巢同种异体移植成功,提示ABO不合不阻碍成功,可能拓展卵巢移植指征。
要点
- 首例需免疫抑制的非同卵女性间卵巢皮质同种异体移植成功。
- ABO血型不合未阻止移植成功,术后5个月恢复月经并自然妊娠。
- 原位放置移植物和手术技术对自然妊娠和较高妊娠率至关重要。
核心结论
- 需安全免疫抑制的同种异体移植若成功,未来可能成为比冻存卵巢移植或同卵双胎间移植更常用的卵巢移植指征。
研究设计与样本
- 病例报告:一名20岁非嵌合型45-XO特纳综合征无月经女性接受其22岁46-XX fertile姐姐的卵巢组织移植。
- 供受体HLA匹配但ABO血型不合,采用华盛顿大学和约翰霍普金斯中心肾移植患者现用的免疫抑制方案。
主要发现
- 术后5个月恢复正常每月月经卵巢功能,并自然妊娠分娩一正常女婴。
- 术后FSH与AMH水平关系持续支持组织压力控制原始卵泡募集的假说。
- ABO血型不合未阻止成功,提示扩散而非血管重建可能足以支持卵巢皮质移植长期存活并自然妊娠。
临床怎么用
- 原位放置移植物和手术技术对自然妊娠和较高妊娠率至关重要。
- 作者认为需安全免疫抑制的同种异体移植若成功,未来可能成为更常用的卵巢移植指征。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether we can safely and successfully transplant an ovary tissue allograft from a nonidentical donor to her Turner syndrome sister. DESIGN: Transplantation of cryopreserved ovary tissue, as well as fresh transplantation of ovarian tissue between identical twins, is now well established with numerous reported successful cases. However, there have not yet been any ovary transplants between nonidentical women requiring immunosuppression (ovary allotransplant). This could be a much more common indication for ovary tissue transplantation if safe and reliable immunosuppression were available. PATIENT(S): A 20-year-old amenorrheic woman with nonmosaic 45-XO Turner syndrome requested ovary tissue transplantation from her fertile 22-year-old 46-XX sister. They were an human leukocyte antigens match but were ABO incompatible, a well-known contra-indication to solid tissue or organ transplantation. The Turner syndrome sister strongly preferred to be able to become pregnant naturally without donor egg in vitro fertilization and to avoid hormone replacement therapy. In her religious group, that would also be important for finding a marital match. Despite the poor prognosis associated with ABO incompatibility, an ovary from her 22-year-old nonidentical fertile sister was transplanted to her employing the immunosuppression protocol now used for kidney transplant patients in our centers at Washington University and Johns Hopkins. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Post operatively at 5 months she developed normal monthly menstrual ovarian function, and she became spontaneously pregnant with a normal infant girl. The relation between her postoperation follicle stimulating hormone and antimüllerian hormone levels continue to support the theory that tissue pressure controls primordial follicle recruitment. The fact that ABO incompatibility did not prevent success suggests that diffusion and not revascularization may be all that is required for successful long-term ovarian cortex transplant survival with spontaneous pregnancy. RESULT(S): Ovary allotransplantation with safe immunosuppression allows natural conception, and also normal hormone function obviates the need for hormone replacement therapy. Orthotopic placement of the graft and surgical technique is critical for natural conception and a higher pregnancy rate. CONCLUSION(S): Allotransplantation requiring safe immunosuppression, if successful, maybe a much more commonly used indication for ovary transplantation in the future than frozen ovary grafts or grafts between identical twins.
引用
- Silber SJ, Goldsmith S, Rubinoff B, et al. First successful ovarian cortex allotransplant to a Turner syndrome patient requiring immunosuppression: wide implications. Fertil Steril. 2024. PMID: 39142463. doi:10.1016/j.fertnstert.2024.08.324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。